Antony Chettoor Invaio Sciences
3 protocols

Christian Sailer Graz University of Technology
5 protocols

Jean Millet INRA French National Institute for Agricultural Research
2 protocols

Juan Facundo Ayala Instituto de Nanociencia y Nanotecnología
32 protocols

Xinlei Li
  • Research scientist, The Abigail Wexner Research Institute at Nationwide Children's Hospital
Research focus
  • non-alcoholic steatohepatitis pathogenesis mechanisms; extracellular vesicle-based potential therapeutic for liver diseases; hepatitis virology.


PhD, University of Chinese Academy of Sciences, 2014

Lab information

David Brigstock lab focuses on the extracellular vesicles-based interplays between parenchymal and non-parenchymal cells in the liver, and potential therapeutic against liver diseases including fibrosis, alcoholic liver disease, and non-alcoholic steatohepatitis.


1. Li, Xinlei, Zhaohui Xu, Bidisha Mitra, Minhang Wang, Haitao Guo, Zongdi Feng Elevated NTCP expression by an iPSC-derived human hepatocyte maintenance medium enhances HBV infection in NTCP-reconstituted HepG2 cells. Cell & Bioscience. 2021. 11(1):123. (doi: 10.1186/s13578-021-00641-1)
2. Li, Xinlei*, Ruju Chen, Sherri Kemper, and David R. Brigstock. Structural and functional characterization of fibronectin in extracellular vesicles from hepatocytes. Frontiers in Cell and Developmental Biology. 2021. 18(9):640667. (doi: 10.3389/fcell.2021.640667) (*Corresponding author)
3. Li, Xinlei and Tao Peng. Strategy, Progress, and Challenges of Drug Repurposing for Efficient Antiviral Discovery. Frontiers in Pharmacology. 2021. 4(12):660710. (doi: 10.3389/fphar.2021.660710)
4. Li, Xinlei, Ruju Chen, Sherri Kemper, and David R. Brigstock. Dynamic changes in function and proteomic composition of extracellular vesicles from hepatic stellate cells during cellular activation. Cells, 2020. 9(2):290. (doi: 10.3390/cells9020290)
5. Li, Xinlei#, Ruju Chen#, Sherri Kemper, and David R. Brigstock. Extracellular Vesicles from Hepatocytes Are Therapeutic for Toxin-Mediated Fibrosis and Gene Expression in the Liver. Frontiers in Cell and Developmental Biology, 2020. 7:368. (doi: 10.3389/fcell.2019.00368) (#co-first author)
6. Li, Xinlei, Jinqian Li, Yetong Feng, Hua Cai, Yi-Ping Li, Tao Peng. Long-chain fatty acyl-coenzyme A suppresses hepatitis C virus infection by targeting virion-bound lipoproteins. Antiviral Research, 2020. 177: 104734. (doi: 10.1016/j.antiviral.2020.104734)
7. Liu, Chang, Wei Cai, Xin Yin, Zimin Tang, Guiping Wen, Charuta Ambardekar, Xinlei Li, Dong Ying, Zongdi Feng, Zizheng Zheng, and Ningshao Xia. An Optimized High-Throughput Neutralization Assay for Hepatitis E Virus (HEV) Involving Detection of Secreted Porf2. Viruses, 2019. 11(1):64. (doi: 10.3390/v11010064)
8. Yin, Xin, Xinlei Li, Charuta Ambardekar, Zhimin Hu, Sebastien Lhomme, and Zongdi Feng. Hepatitis E virus persists in the presence of a type III interferon response. PLoS pathogens, 2017. 13(5): e1006417. (doi: 10.1371/journal.ppat.1006417)
9. Yin, Xin, Xinlei Li, and Zongdi Feng. Role of Envelopment in the HEV Life Cycle. Viruses, 2016. 8(8):229. (doi: 10.3390/v8080229)
10. Cai, Hua, Wenxia Yao, Leike Li, Xinlei Li, Longbo Hu, Ruiming Mai, and Tao Peng. Cell-death-inducing DFFA-like Effector B Contributes to the Assembly of Hepatitis C Virus (HCV) Particles and Interacts with HCV NS5A. Scientific reports, 2016. 6: 27778. (doi: 10.1038/srep27778)
11. Li, Xinlei, Rong Zhou, Tao Peng (2015). The current progress in the development of hepatitis C virus cell culture systems. Chin J Viral Dis. 5(1):58-66.
12. Yao, Wenxia#, Hua Cai#, Xinlei Li, Ting Li, Longbo Hu and Tao Peng (2014). Endoplasmic reticulum stress links hepatitis C virus RNA replication to WT-PGC-1α/L-PGC-1α upregulation. J. Virol. 88(15):8361-74. (doi: 10.1128/JVI.01202-14) (#co-first author)
13. Li, Xinlei#, Hanfang Jiang#, Linbing Qu, Wenxia Yao, Hua Cai, Ling Chen and Tao Peng (2014). Hepatocyte Nuclear Factor 4α and Downstream Secreted Phospholipase A2 GXIIB Regulate Production of Infectious Hepatitis C Virus. J Virol 88(1): 612-627. (doi: 10.1128/JVI.02068-13) (#co-first author)
14. Li, Xinlei, Wenxia Yao, Tao Peng. Chapter 27 Polyomaviridae. In: Douglas D. Richman, Richard J. Whitley, and Frederick G. Hayden Editor. Clinical Virology (3rd Edition) (Chinese Edition). Beijing, Science Press; 2012. ISBN-10: 9787030339430.
李新磊,姚文霞,彭涛 译. 第27章 多瘤病毒. D.D.里奇曼 等 编 临床病毒学. 陈敬贤,周荣,彭涛 等 主译。北京;科学出版社,2012.
2 Protocols reviewed
Cytopathic Effect Assay and Plaque Assay to Evaluate in vitro Activity of Antiviral Compounds Against Human Coronaviruses 229E, OC43, and NL63
Authors:  Yanmei Hu, Chunlong Ma and Jun Wang, date: 02/05/2022, view: 2552, Q&A: 0

Coronaviruses are important human pathogens, among which the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent for the COVID-19 pandemic. To combat the SARS-CoV-2 pandemic, there is a pressing need for antivirals,

More >
A Pipeline for Non-model Organisms for de novo Transcriptome Assembly, Annotation, and Gene Ontology Analysis Using Open Tools: Case Study with Scots Pine
Authors:  Gustavo T. Duarte, Polina Yu. Volkova and Stanislav A. Geras’kin, date: 02/05/2021, view: 4866, Q&A: 0

RNA sequencing (RNA-seq) has opened up the possibility of studying virtually any organism at the whole transcriptome level. Nevertheless, the absence of a sequenced and accurately annotated reference genome may be an obstacle for applying this

More >
We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.